These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 12536921)
21. The management of lymph node metastasis from bladder cancer. Simms MS; Mann G; Kockelbergh RC; Mellon JK Eur J Surg Oncol; 2005 May; 31(4):348-56. PubMed ID: 15837038 [TBL] [Abstract][Full Text] [Related]
22. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
23. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024 [TBL] [Abstract][Full Text] [Related]
24. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer. Pectasides D; Pectasides M; Economopoulos T Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429 [TBL] [Abstract][Full Text] [Related]
25. The role of histological examination for prognostic evaluation and therapeutic algorithm in urinary bladder tumors. Traşcă E; Buzulică R; Pleşan C; Nicolescu I Rom J Morphol Embryol; 2005; 46(3):225-8. PubMed ID: 16444309 [TBL] [Abstract][Full Text] [Related]
26. [Drug therapy of poorly responding tumors in the metastatic stage]. Gremmel H; Liffers R Med Welt; 1980 Oct; 31(43):1554-6. PubMed ID: 7464515 [No Abstract] [Full Text] [Related]
28. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
30. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice]. Junker K; Pilchowski R; Stöhr R; von Eggeling F; Schubert J; Hartmann A Urologe A; 2007 Sep; 46(9):1288. PubMed ID: 17593341 [No Abstract] [Full Text] [Related]
31. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076 [TBL] [Abstract][Full Text] [Related]
32. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy. Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943 [TBL] [Abstract][Full Text] [Related]
33. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years. Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744 [TBL] [Abstract][Full Text] [Related]
40. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. Steven K; Poulsen AL J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]